Warfarin Cuts Mortality, Thromboembolism After Valve Replacement

THURSDAY, Jan. 4, 2024 -- Warfarin use after bioprosthetic surgical aortic valve replacement (sAVR) is associated with lower all-cause mortality and a decreased risk for thromboembolism compared with not receiving warfarin, according to a study...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news